{"id":7960,"date":"2025-12-12T11:01:18","date_gmt":"2025-12-12T16:01:18","guid":{"rendered":"https:\/\/web.uri.edu\/pharmce\/?p=7960"},"modified":"2026-06-25T12:53:20","modified_gmt":"2026-06-25T16:53:20","slug":"mhc-pharmacy-law-course","status":"publish","type":"post","link":"https:\/\/web.uri.edu\/pharmce\/mhc-pharmacy-law-course\/","title":{"rendered":"MHC Pharmacy Law Course"},"content":{"rendered":"\n<div style=\"height:34px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<section class=\"cl-wrapper cl-video-wrapper\"><div class=\"cl-video  \"><div class=\"overlay\"><h1>MHC Pharmacy Law Course<\/h1><\/div><div class=\"poster\" id=\"wgjn22k6T7Y\" data-video=\"wgjn22k6T7Y\" data-platform=\"youtube\" data-showinfo=\"0\"><img decoding=\"async\" src=\"https:\/\/web.uri.edu\/pharmce\/wp-content\/uploads\/sites\/1382\/mhclaw.jpg\" alt=\"mhclaw\"\/><\/div><\/div><\/section>\n\n\n<h2 class=\"wp-block-heading\">Presented by: Dennis Lyons, BS, RPh &amp; Karla Palmer, J.D.<\/h2>\n\n\n<a class=\"cl-button   prominent\" href=\"https:\/\/www.uripharmacycpd.org\" title=\"\">Register &#8211; $20.00<\/a>\n\n\n<h1 class=\"wp-block-heading\">Overview<\/h1>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p>This home-study pharmacy law program provides an in-depth review of new and pending Massachusetts pharmacy legislation, along with recent federal regulatory updates related to the compounding of controlled substances. Originally presented as a live continuing education activity on December 2, 2025, this recorded session offers timely and practical guidance for pharmacists navigating an evolving legal and regulatory landscape.<\/p>\n\n\n\n<p>Participants will examine how state and federal laws shape pharmacy practice, define professional responsibilities, and influence day-to-day operational decision-making. The program highlights key regulatory principles governing compounding practices and the handling of controlled and other sensitive medications. In addition, learners will gain insight into the legislative and regulatory processes and explore strategies for effectively engaging with policy development that impacts the profession.<\/p>\n\n\n\n<p>This activity is approved for <strong>2.0 contact hours (0.2 CEUs) of pharmacy law continuing education home study credit<\/strong>.<\/p>\n\n\n<section class=\"cl-wrapper cl-boxout-wrapper\"><div class=\"cl-boxout  \"><h1>Target Audience<\/h1>\n\n<p>Pharmacists in all practice settings.<\/p>\n\n<\/div><\/section>\n\n<section class=\"cl-wrapper cl-boxout-wrapper\"><div class=\"cl-boxout  \"><h1>Learning Objectives<\/h1>\n\n<p>Upon completion of this educational activity, pharmacists will be able to:<\/p>\n\n\n\n<p><strong>Dennis Lyons, BS, RPh<\/strong><br><em><strong>2025 Massachusetts Legislative Update<\/strong><\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Explain differences between legislation and regulation.<\/li>\n\n\n\n<li>Identify pending and past legislation impacting pharmacists in Massachusetts.<\/li>\n\n\n\n<li>Review existing laws and regulations that have changed the scope of pharmacist practice.<\/li>\n\n\n\n<li>Identify specific strategies and actions that can be taken by pharmacists to affect the legislative process.<\/li>\n<\/ul>\n\n\n\n<p><strong>Karla Palmer, J.D.<\/strong><br><em><strong>Is the Future Formulated? Compounding of Controlled Substances in 2025<\/strong><\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Explain the differences between FDCA Sections 503A and 503B as they relate to compounding with controlled substances.<\/li>\n\n\n\n<li>Define &#8220;anticipatory compounding&#8221; as it is applied under current FDA and DEA guidance.<\/li>\n\n\n\n<li>Discuss the concept of constructive transfer of controlled substances and related regulatory implications.<\/li>\n\n\n\n<li>Describe the DEA&#8217;s current requirements and monitoring expectations for compounding facilities handling controlled substances.<\/li>\n<\/ul>\n\n<\/div><\/section>\n\n<section class=\"cl-wrapper cl-boxout-wrapper\"><div class=\"cl-boxout  \"><h1>Technology<\/h1>\n\n<p>A mobile device or computer with an internet connection is required.<\/p>\n\n<\/div><\/section><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\"><div class=\"cl-wrapper cl-card-wrapper\"><a class=\"cl-card  \" href=\"https:\/\/www.acpe-accredit.org\/program\/continuing-education-provider-accreditation\/\" title=\"\"><div class=\"cl-card-container media\"><img decoding=\"async\" src=\"https:\/\/web.uri.edu\/pharmce\/wp-content\/uploads\/sites\/1382\/acpelogo-288x300.jpg\" srcset=\"\" alt=\"\"><\/div><div class=\"cl-card-container text\"><div class=\"cl-card-text\"><h2>Accreditation Statement<\/h2><p>The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.<br><br>This knowledge-based program will provide 2.0 Contact Hour (0.2 CEU) for pharmacists.<br><br><strong>UAN: 0060-9999-25-055-H03-P<\/strong><br>Release Date: December 15, 2025<br>Expiration Date: December 15, 2026<\/p><\/div><\/div><div class=\"cl-card-container button\">ACPE<\/div><\/a><\/div><\/div>\n<\/div>\n\n\n\n<h1 class=\"wp-block-heading\">Speakers<\/h1>\n\n\n<section class=\"cl-wrapper cl-boxout-wrapper\"><div class=\"cl-boxout  \"><h1>Dennis Lyons, B.S., R.Ph.\nDGL Healthcare Consulting\u00a0<\/h1>\n\n<p><strong>Dennis Lyons\u00a0<\/strong>is an accomplished expert in pharmacy healthcare law and regulations. He\u00a0owns and manages DGL Healthcare Consulting, where he provides strategic public policy and regulatory counsel and government relations support in the pharmacy and cannabis industries.\u00a0\u00a0Mr. Lyons has extensive experience in pharmacy and health care with over 40 years of experience in public,\u00a0private\u00a0and academic organizations at the senior management level.\u00a0\u00a0He regularly consults with boards, public officials, health care leaders, and professional associations on health care policy and legislative advocacy.\u00a0Mr. Lyons currently\u00a0represents\u00a0the Massachusetts Independent Pharmacists Association (MIPA) providing legislative advocacy on such matters as PBM reform, Pharmacist Provider\u00a0Status\u00a0and compensation for pharmacy services. Mr. Lyons holds a B.S. from MCPHS University and is a registered pharmacist.\u00a0 He frequently lectures on\u00a0the topic of regulatory\u00a0affairs.\u00a0<\/p>\n\n<\/div><\/section>\n\n<section class=\"cl-wrapper cl-boxout-wrapper\"><div class=\"cl-boxout  \"><h1>Karla Palmer, J.D.\nDirector, Hyman, Phelps &amp; McNamara, PC\u00a0<\/h1>\n\n<p>As a litigator with over 33 years\u2019 experience, Karla advises clients throughout the\u00a0pharmaceutical supply chain \u2013 from manufacturers and distributors to outsourcing facilities,\u00a0pharmacies and doctors \u2013 on a range of legal and regulatory issues. These matters include DEA\u00a0and FDA regulations and guidance, government inspections and investigations, Form 483\u00a0observations, warning letters, consent decrees, and administrative and federal proceedings. She\u00a0represents\u00a0entities and individuals in matters involving their DEA registration, including\u00a0investigations, orders to show cause, immediate suspension matters,\u00a0hearings\u00a0and federal appeals\u00a0of\u00a0the same. Karla is a nationally recognized leader in the compounding space, both for Section\u00a0503A and 503B facilities. She regularly\u00a0counsels\u00a0clients on all aspects of compliance with state\u00a0and federal statutes,\u00a0regulations\u00a0and guidance. Karla has written about and addressed industry\u00a0audiences across the country on FDA and compliance matters, including all aspects of the\u00a0passage and implementation of the 2013 Drug Quality and Security Act including both\u00a0compounding and supply chain issues,\u00a0its guidance\u00a0documents, and implementing regulations.\u00a0<\/p>\n\n<\/div><\/section>\n\n\n<h1 class=\"wp-block-heading\">Requirements for Credit<\/h1>\n\n\n\n<p>Completion of the online educational activity and a program evaluation are required to earn credit. No partial credit is available for this program. Evaluations must be completed at <a href=\"http:\/\/www.uripharmacycpd.org\">www.uripharmacycpd.org<\/a> within 60 days. This program offers 2.0 contact hours (0.20 CEUs) of pharmacy law CE for Pharmacists.<\/p>\n\n\n<section class=\"cl-wrapper cl-boxout-wrapper\"><div class=\"cl-boxout  \"><h1>Evaluation<\/h1>\n\n<p>All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs.<\/p>\n\n<\/div><\/section>\n\n\n<div style=\"height:52px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h1 class=\"wp-block-heading\">Registration<\/h1>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\"><section class=\"cl-wrapper cl-boxout-wrapper\"><div class=\"cl-boxout  \"><h1>The accreditation service fee for this program is $20.00<\/h1>\n\n<p><\/p>\n\n<\/div><\/section>\n\n<a class=\"cl-button   prominent\" href=\"http:\/\/www.uripharmacycpd.org\" title=\"\">Register to Claim CE Credit<\/a><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><strong>Steps to complete the program and claim credit:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Watch the video at the top of this page.<\/li>\n\n\n\n<li>Login or create an account in LUX LMS, URI&#8217;s learning management and CE reporting system, using your email address and professional license number. Complete all required account set up fields to ensure accurate CE reporting.<\/li>\n\n\n\n<li>Select &#8220;Available On-Line Activities&#8221; or &#8220;Home Study Programs&#8221; to find the educational activity.<\/li>\n\n\n\n<li>Select Take Post-Test and proceed to secure online payment (Visa, MC, AMEX, Discover and Electronic Checks are accepted).<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:57px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h1 class=\"wp-block-heading\">Statement of Disclosure<\/h1>\n\n\n\n<p>In accordance with the Accreditation Council for Pharmacy Education (ACPE) Standards for Continuing Pharmacy Education, The University of Rhode Island College of Pharmacy requires that program faculty disclose any relationship (e.g., shareholder, recipient of research grant, consultant or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations. No one involved in the planning of this program has any relevant financial relationships to disclose.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This\u00a0MHC\u00a0program offers an overview of how laws and regulations shape pharmacy\u00a0practice\u00a0and influence professional responsibilities. Participants will explore how evolving policies affect the scope of practice and operational expectations for pharmacists. The session also highlights key regulatory concepts that guide compounding and the handling of sensitive medications. Finally, attendees will gain strategies to effectively engage in and influence the legislative and regulatory process.<\/p>\n<h5>This activity is available to access free of charge.<\/h5>\n<p><i>If you wish to claim CE credit for participation there is a $20.00 accreditation service fee which is paid when you register for the course.<\/I><\/p>\n","protected":false},"author":639,"featured_media":7963,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[10],"tags":[22],"class_list":["post-7960","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-homestudy","tag-pharmacy-ce-accredited"],"acf":[],"_links":{"self":[{"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/posts\/7960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/users\/639"}],"replies":[{"embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/comments?post=7960"}],"version-history":[{"count":4,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/posts\/7960\/revisions"}],"predecessor-version":[{"id":8336,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/posts\/7960\/revisions\/8336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/media\/7963"}],"wp:attachment":[{"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/media?parent=7960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/categories?post=7960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/tags?post=7960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}